and this comes dementia, alzheimer's. and this co m es after dementia, alzheimer's.tment. a great number of trials and many of the trials, although indicating initial promise, did not fulfil that promise. but in this case, more than 3000 people went through the trial and ata 3000 people went through the trial and at a high dose it can reduce symptoms in patients when it is called early. it can reduce a range of mental disabilities. 25% less decline after 18 months which is significant. and it talks about how many big pharmaceutical companies have been investing a lot of money for years. they have failed, many of them pulled out. whereas biojan kept going. i was going to look at their shares. it does not feel quite right right now. but it does cost so much money, research and development into funding anything that might help and yet it is a game changer when they get it. western countries andjapan, when they get it. western countries and japan, where the population is ageing and this is one of those sad fa cts ageing and this is one of those sad facts mental decline d

yeah, it would be the biggest thing that's happened in alzheimer's — ever.blished trial data before they decide whether to grant it a licence. they'll be very cautious indeed. it's relatively immature data. they'll be looking incredibly closely at that and normally what they would want to see is a second study, to confirm those results. if aducanumab passes all its regulatory hurdles, it's still likely to be another two—three years before it comes on the market here in the uk. it will undoubtedly be are expensive but it could also be transformative for patients, giving them crucial extra years of quality life. and enjoying life together is what matters to charman and phillip — living with dementia, not defined by it. fergus walsh, bbc news. air accident investigators say that an aeroplane crash in indonesia last year, which killed 189 people, was caused by design flaws as well as human error. the lion air plane — a boeing 737 max — crashed into the sea last october. a second aircraft of the same model crashed in ethiopia five months later. our business corre

nearly 6 million people in this country have alzheimer's disease.eatme fully stop it yet, but researchers around the world are trying to crack the complicated puzzle. tonight, miles o'brien reports on iriguing research and a different approach to battling the disease. f someat work is funded by retired senator jay rockefeller. this story is part of our at the leading edge of science. >> hello, everybody. >> to know judy pollock is to love her. she brims with energy, kindness, and humor. >> at first you >> would never know. >>>> i can't remember what i did yesterday, but i can remember stacy from 30 years ago. eventually her disease reveals what it stealing. her memory. >> can i have my key >> at age 61, judy is five years into her new normalqu after obdiagnosis. she has alzheimer's disease. >> i would go to say something and it just didn't come out. probably just like i'm talking now. it i difficult to have a fluent conversation. >> she was a neonatal nurse practitioner with a doctoral husban mark is a neonatologist. so they dove into this case, the

yeah, it would be the biggest thing that's happened in alzheimer's, ever.efore they decide whether to grant it a licence. they'll be very cautious indeed. it's relatively immature data. they'll be looking incredibly closely at that and normally what they would want to see is a second study, to confirm those results. if aducanumab passes all its regulatory hurdles, it's still likely to be another two to three years before it comes on the market here in the uk. it will undoubtedly be expensive, but it could also be transformative for patients, giving them crucial extra years of quality life. and enjoying life together is what matters to charman and philip — living with dementia, not defined by it. fergus walsh, bbc news. all week pressure has been increasing on donald trump over allegations he broke the law by asking ukraine's leader to dig up damaging information on the son of his democratic rival, joe biden. that's led to president trump being subject to an impeachment inquiry — a process where those in high office are investigated for serious misconduct, w

i know that in the netherlands, they treat alzheimer's very differently.y to get them to do everything that you just listed, and just do it by rote this is a pill that would take care -- nursing, the whole concept of senior living would change. >> they are also, by the way, going to offer the drug to eligible patients that were previously enrolled in the phase three studies. if it is working, why wouldn't you want to take it? they plan to file for the license for the drug in early 2020 and they'll continue a dialogue as well with regulatory authorities and markets that include europe and japan all these aging populations the world over one can only imagine what this drug could actually mean if it does work. >> i'm going to say -- >> if it does get approval and does successfully retard the progression of the disease and if or roll it back >> i'll say something nutty, but maybe 80 points is not enough. maybe it deserves to be even more you have the number one drug of all time, potentially. >> meg tirrell just talked to the ceo, has more on what is an importa

nearly six millionoueople in thisry have alzheimer's disease. tragically, no treatment can fully stop it yet. but researchers around the worlr arng to crack the complicated puzzle that is alzheimer's. tonight, miles o'brien reportsre on intriguinarch and a different approach to battling the disease. for the record, some of that work is funded by retired senator jay rockefeller. his wife sharon is the c.e.o. of weta, which owns the newshour.ar his story is pt of our regular look at "the leading edge" of science. >> hello everybody! >> judi! >> reporter: to know judi polak is to love her. >> i love you guys. >> reporter: she brimskiith energy, ness and humor. >> did i tell you about that? can u believe that? >> reporter: at first you wouldp never know... >> i mean i cat remember what i did yesterday, but i can remember stacy from 30 years ago. >> reporter: ...but eventually, her disease reveals what it is stealing; her memory.>> ll rht, i am looking for my keys. of course this is the day i can't find them. >> reporter: at age 61, judi polak is now

. >>> a new hope for patients and families dealing with alzheimers. dr. tell us everything we need to know about this. that's next. i get it all the time. "have you lost weight?" of course i have- ever since i started renting from national. because national lets me lose the wait at the counter... ...and choose any car in the aisle. and i don't wait when i return, thanks to drop & go. at national, i can lose the wait...and keep it off. looking good, patrick. i know. (vo) go national. go like a pro. most people think of verizon as a reliable phone company. (woman) but to businesses, we're a reliable partner. we keep companies ready for what's next. (man) we weave security into their business. virtualize their operations. (woman) and build ai customer experiences. we also keep them ready for the next big opportunity. like 5g. almost all the fortune 500 partner with us. (woman) when it comes to digital transformation... verizon keeps business ready. ♪ fidelity has zero commissions for online u.s. equity trades and etfs, plus zero minimums to open a brokerage

we will not be able to cure alzheimer's. and that would be the crime of the century, because the science is galloping right now. we have gene therapy and cell therapy and immunotherapy, we have all this amazing science and we can cure and treat every disease known to man. we create 57% of all the drugs in the world, more than the rest of the world combined. and most of the drugs innovated in europe and asia are innovated for our market, because we have the only free market where people can get their money back for the drugs that they invent. and we should be proud of that. we get access to drugs that people in other countries don't. we have 2 million people working in this industry. we lead the world in it. we provide all of the hope for most of the sick people in the world. why would we want to destroy that for some shortsighted political gain? peter: to return to the out-of-pocket cap, that largely is not reducing the amount the drug company is getting paid. so i wonder, are there any solutions you would agree to, or not b

and a new drug that could slow down alzheimer's disease. early tests by a us company are promising.nd welcome to our look ahead to what the the papers will be bringing us tomorrow. with me arejohn stevens, the deputy political editor of the daily mail, and political writer and academic maya goodfellow. most of tomorrow's front pages are now in. let's start with the financial times, and it leads with those crunch brexit votes in which borisjohnson won the backing of mps for his deal, but was defied over his timetable. brexit is in purgatory, roars the telegraph, quoting jacob rees—mogg, the leader of the house, following those votes by mps. "yeah but no but." that's the headline in the sun as the government both wins and loses those two votes in quick succession. the daily mail celebrates boris johnson's victory in the vote on his deal, but says mps turned triumph into disaster by forcing him to put it on hold. the metro says that, after hitting the pause button on his brexit legislation, the prime minister will now ask the eu how it wants to proceed. as mps reject boris johnson's br

yeah, it would be the biggest thing that's happened in alzheimer's, ever.hether to grant it a licence. they'll be very cautious indeed. it's relatively immature data. they'll be looking incredibly closely at that and normally what they would want to see is a second study, to confirm those results. if aducanumab passes all its regulatory hurdles, it's still likely to be another two to three years before it comes on the market here in the uk. it will undoubtedly be expensive, but it could also be transformative for patients, giving them crucial extra years of quality life. and enjoying life together is what matters to charman and philip — living with dementia, not defined by it. fergus walsh, bbc news. a second man has been charged with murder, after two 17 year old boys were killed at a house party in milton keynes. the teenagers, named as dom ansah and ben gillham—rice, died as a result of knife injuries after they were attacked. thames valley police say they've charged 22 year old earl bevans with two counts of murder and two counts of attempted murder — a

alzheimer's breakthrough — a us company says it's ready to market a new drug that can slow down the diseaselenging taboos — why a culture of modesty is standing in the way of the fight against breast cancer in pakistan. welcome to the programme. it's 8am in singapore and 1am here in london, where brexit is once again in turmoil, after prime minister borisjohnson suffered a major defeat in parliament. mps voted to reject his fast track timetable to pass the eu withdrawal agreement through the house of commons. mrjohnson did actually win another vote to advance the legislation, itself a significant victory. but the timetable defeat means he's been forced to pause the whole process, which means a new brexit extension may be needed. our political editor laura kuennsberg reports. a rare moment of silence... and then a result. the ayes to the right 308, the noes to the left 322. mps kicked out the prime minister's timetable for speeding his brexit deal through parliament. plenty of mps don't want to leave but even for those who do, a majority in here tonight thought it was happening too fast. ton

alzheimer's breakthrough — a us company says it's ready to market a new drug that can slow down the disease the latest twist in the saga of britain trying to leave the european union, prime minister borisjohnson has suffered another major defeat in parliament. mps voted to reject his fast—track timetable to pass the eu withdrawal agreement through the house of commons. he did actually win another vote to advance the legislation, itself a significant victory. but the timetable defeat means he's been forced to pause the whole process, which means a a new extension may be needed, from european leaders. this from our political editor laura kuennsberg. a rare moment of silence... and then a result. the ayes to the right 308, the noes to the left 322. mps kicked out the prime minister's timetable for speeding his brexit deal through parliament. plenty of mps don't want to leave but even for those who do, a majority in here tonight thought it was happening too fast. tonight the house has refused to be bounced into debating a hugely significant piece of legislation in just two days with barely any

i want to ask you about alzheimer's. alzheimer's is the sixth leading cause of death in the united states. there are 5.8 million people living with the disease, and another 16 million taking care of those individuals but not being compensated for it. as president, what would you do to fight alzheimer's and end this public health crisis? gov. bullock: it is a public health crisis. to me it is not just all about statistics. when we talk about dementia and alzheimer's, the woman from a rap -- the woman from aarp spoke of -- this has faces and names. it is grandpa bill, my grandfather, and grandma rosie. when grandma got dementia and alzheimer's. it was my political mentor, and attorney general. there are a couple of things we need to look at along the way. spendnow, we as a nation billion a year when it comes to the care, treatment, and prevention of alzheimer's. if we do not do something about this by 2040, it will be $500 billion. we know the numbers are out there along the way. we know where this is going to go if we do

biog n posting the pest best day in 20 years after the alzheimer's drug shows promise more the breakthrough. with you we begin with breaking news on nike the ceo mark parker is stepping down, replaced by nike board minneapolis and service now ceo john donaho, marker will be the executive chairman we heard from parker exclusively on the "closing bell." >> we have spent a lot of time over many months working on succession planning. so this is -- this is not something that happens in a matter of weeks. so it's really unrelated to oregon project or other issues this is about me on the board really wanting to make the -- build on the momentum we've got. add the horsepower, accelerate against our strategy and do it while i'm here and in a position to lean in and make this as successful as possible >> parkers' departure comes a the dame the crow kevin planning leaving his post in the new year as well. both stort sporting stocks time to lays up and buy or sit on the sidelines. >> can you just say that. >> i just did. do you have ears >> i do. it hurt my ears. you're sproech so much smarter than tha

and a new drug that could slow down alzheimer's disease. early tests by a us company are promising. coming up on sportsday on bbc news. england coach eddiejones claims his side were spied on — ahead of their rugby world cup semi—final against new zealand. good evening from westminster where, for the very first time, the house of commons has voted in favour of a brexit agreement — but crucially — it's rejected the prime minister's timetable — for passing the necessary legislation. the first of two votes tonight was on the withdrawal agreement bill — the main brexit legislation — which runs to 110 pages, and turns the prime minister's brexit deal into law. the government won that by 329 votes to 299, a majority of 30. but it then lost the second vote, on the parliamentary timetable, by m votes, because a majority of mps did not think that two days was long enough, to scrutinise such an important bill. the prime minister said the bill would now be paused, and the eu has signalled tonight that it will accept the uk's request for another brexit delay. 0ur political editor laura kuenssber

and a new drug that could slow down alzheimer's disease — early tests by a us company are promising.11:30, we'll be taking another look at the papers withjohn stevens, deputy political editor of the daily mail and political writer and academic maya goodfellow. good evening. the house of commons has voted in favour of a brexit agreement but, crucially, it's rejected the prime minister's timetable for passing the necessary legislation. the first of two votes tonight, was on the withdrawal agreement bill — the main brexit legislation — which runs to 110 pages and turns the prime minister's brexit deal into law. the goverment won that by 329 votes to 299 — that's a majority of 30. but it lost the second vote on the parliamentary timetable by m votes because a majority of mps did not think that three days was long enough to scrutinise such an important bill. the prime minister said that the bill would now be paused and the eu has signalled tonight that it will accept the uk's request for an extension. our political editor laura kuenssberg reports on tonight's brexit votes. a rare moment o

also in the programme... is this a turning point in the treatment of alzheimer's? the us drug company biogen says it's seeking approval for a drug which appears to slow the disease. and... should a 30—something launch a dating app for the over—50s? we'll catch up with the entrepreneur behind it. a marriage of planning expertise with a multicultural background. we'll get the inside track on how to compete in the crowded wedding planning field. the founder of la fete joins us live. and we want to know is a dating out the best way to meet a potential partner? how did you meet yours? and if you are single, do you use dating apps? let us know — just use the hashtag bbcworklife. hello and a warm welcome to worklife. many have you have been in touch already about how you met your partner, it is great to see your stories and keep them coming, we will mention a few later. we start in the uk, where developments in the house of commons yesterday have prolonged the uncertainty over brexit. mps initially backed prime minister boris johnson's withdrawal agreement to take britain

yeah, it would be the biggest thing that's happened in alzheimer's — ever.a before they decide whether to grant it a licence. they'll be very cautious indeed. it's relatively immature data. they'll be looking incredibly closely at that and normally what they would want to see is a second study, to confirm those results. if aducanumab passes all its regulatory hurdles, it's still likely to be another two—three years before it comes on the market here in the uk. it will undoubtedly be are expensive but it could also be transformative for patients, giving them crucial extra years of quality life. and enjoying life together is what matters to charman and phillip — living with dementia, not defined by it. fergus walsh, bbc news. now it's time for a look at the weather with chris fawkes hello there, heavy outbreaks of rain will continue to affect parts of england and wales but it is across the south of wales that the met office have issued their amber weather warning. we could get around hundred 20 millimetres of rain, more than enough to cause flooding problems.

but the truth is alzheimer's is devastating.function but emotionally problematic. they can have psychos sees. it can affect the family. everyone wants cure for alzheimer's disease. plaques entertaining gels causing symptoms. trump administration is looking to get potentially life saving drugs on the market faster. historically it used to take much longer. perhaps they're pushing forward because they do have some confidence that these results are actually going to work. i'm cautiously optimistic. i'm very excited about this. charles: so am i. this is really, that was great to hear the news. i'm glad you were able to help us with this. >> thanks for having me. charles: we're heading out to las vegas next to get a sneak-peek at ford's most powerful mustang ever. we're an hour away from president trump's in pennsylvania to double down on fracking. elizabeth warren wants to back it day one in office. stay tuned to fox business for his speech. ♪. st-in-class platforms and education. i see award-winning service, and a trade desk full o

biotech firm biogen surprised investors when it said the experimental alzheimer's treatment was ready for the regulatory approval press. as you may recall, seven months ago the company discontinued the study of the drug which some expected to be the next blockbuster. analysts say the profit potential is huge because there are no current therapies to reverse affects of the disease. a disease affecting millions and projected to affect millions more in the years to come. the news sent smars of biogen 26%, the best one-day gain since 1996. but as meg tyrell reports while there is hope there is a long road ahead. >> it was a diagnosis you don't expect in the early0s. jeff was only 51 when he was told he has early on set alzhmer'ss disease with no drugs approved to slow alzheimer's's progression he enrolled in a clinical trial of an experimental drug made by biogen designed to attack the am many oid planting build up in the brain kwh he you participate in the clinical trial or the experience for me participating in the clinical trial troo was one of add las vegas i was happy to to be part o

yeah, it would be the biggest thing that's happened in alzheimer's, ever.they'll be very cautious indeed. it's relatively immature data. they'll be looking incredibly closely at that and normally what they would want to see is a second study, to confirm those results. if aducanumab passes all its regulatory hurdles, it's still likely to be another two to three years before it comes on the market here in the uk. it will undoubtedly be expensive, but it could also be transformative for patients, giving them crucial extra years of quality life. and enjoying life together is what matters to charman and philip — living with dementia, not defined by it. fergus walsh, bbc news. the former us president barack obama has paid tribute to the prominent democrat, elijah cummings, who died last week. the clintons and house speaker, nancy pelosi were also among the speakers at the congressman's funeral in baltimore. here's a clip from mr obama's eulogy. the honourable elijah e cummings. you know, this is a title that we confer on all kinds of people who get elected to pub

i want to ask you about alzheimer's. allison heim esper is the sixth leading cause of death in the united states. there are about 5.8 million people living with the disease and another 16 million taking care of those individuals but not being compensated for it. so as president what would you do to fight alzheimer's and this public health crisis? >> and it is a public health crisis and to me it's not just all about statistics. when we talk about dementia and alzheimer's sort of as the woman from aarp spoke of -- to me that has faces and names. it's grandpa bill who was my grandfather and grandma rosy when rosy got dementia then amaze heimers, or my political mentor, an attorney general. a guy named joe mizurik. there are a couple of things we need to look at along the way. right now we as a nation spend about $200 billion a year when it comes to the care treatment and prevention of alzheimer's. if we don't do something about in by 2040 it will be 500 billion. we know the numbers are out there along the way, right? we kno

regulators to approve its extremity therapy for alzheimer's disease.nalysis of data from two clinical trials showed promising results. that is your business flash update. coming up, more on that biogen story and the revival of that experiment alzheimer's treatment. those details ahead. guy: let's take a look at what is happening in the broader markets. the s&p fairly flat, the stoxx 600 fairly flat. we are seeing a move in the u.s. 10 year right now, prices rising in such. the pound flat-ish. not yet at $1.30. we will see what happens through the rest of the day. this is bloomberg. ♪ everyone uses their phone differently. that's why xfinity mobile lets you design your own data. you can share 1, 3, or 10 gigs of data between lines, mix in lines of unlimited, and switch it up at any time. all with millions of secure wifi hotspots and the best lte everywhere else. it's a different kind of wireless network, designed to save you money. switch and save up to $400 a year on your wireless bill. plus, get $250 back when you buy an eligible phone. that's simple.

thought was half the persons with alzheimer's in the united states come from california. i wrote it and when i saw it again i thought, i was startled it was a very collaborative meeting. >> thank you, dianne. any comments or questions? >> thank you for bringing up the issue of the census. i serve on the complete county for the 2020 census. we met last friday and there were two big gaps that were noted. that was the lgbtq community, as well as with people with disabilities. as we are moving to be a little bit more inclusive and reimagining who we are, i am hoping maybe at the next meeting, if you could issue a report on what the department is doing regarding outreach for the census. >> we can definitely do that. we just started having conversations with them, and one of our concerns is the huge portion of census data that will be taken by e-mail, or taken electronically versus by mail. of course, that is a concern for. >> i am the executive director of the and how supportive housing public authority, but i'm here today on behalf of the long-term coordinating council, which

a us company says its developed the first drug that can slow down alzheimer's disease.nd england mind games ahead of the rugby world cup semi final. coach eddiejones says the pressure‘s on the all blacks. and in sport on bbc news — after a torrid start to the season for tottenham, can they get back on track in the champions league later? they host red star belgrade. good evening from westminster, where in an hour's time mps will begin voting on the prime minister's brexit deal. if he wins he'll be a step closer to delivering his promise of brexit on 31st october. if he loses he could abandon his brexit legislation and push instead for a general election, but what's in the deal mps are voting on shortly? it includes a transition period when the uk will still abide by the eu's rules to give time to negotiate a new trade deal. it ensures that eu and uk citizens retain their rights on residency and social security and it says the uk will pay around £33 billion to the eu in a so—called divorce bill, but it ditches the backstop that was in theresa may's deal — and instead ess

yearsd alzheimer's for 10 . fortunately we were able to get the money to take care of her and her needs. also my cousin is in federal prison. i want to thank you for the just society bill you just represented. my question to you for all of us young millennials out there in our 20's and 30's, and it just starting out from college, what can we do, not just on social media, which we can see a change from that. i mean look at what you've come play spray but what can we do in actions outside of social media that can help you. because we know it is a lot of work that you are doing in all areas of government. and all the things that we brought up today in the town hall meeting. but what can we do to help you and your platform to thrive and really helped change this government. rep. ocasio-cortez: thank you so much. that is a really great question. one of the things i think is , it is not is that just about helping me. a larger am part of grassroots movement. people, because critical mass of people have demanded justice

my 91-year-old mother has alzheimer's so i know how important caregivers are. h.r. 4334 strengthens our focus on combating social isolation, which greatly increases the risk of stroke, heart disease, dementia, and premature death t does so by incorporating social isolation screening into the health and supportive services that seniors receive and by empowering local organizations to evaluate solutions for social isolation. the dignity in aging act also establishes a national research demonstration and evaluation center for the aging network. this center will be responsible for conducting, promoting, and coordinating research, including evaluation and demonstration projects, and related technical assistance through the act. the center will increase the repository of information on evidence-based programs and interventions available to the aging network. the bill improves economic opportunity and engagement for older americans. it includes individuals who are just as involved as the priority population for the senior community service employment program. the bill

buscando aprobación de la administración de drogas. >> para ver estos medicamentos. >> del alzheimerctualizaciones del tiempo.>> acias y nos mant también viendo lo que está sucediendo con las condiciones actualmente estamos viendo el área de la bahía. >> donde también estamos de lo que está sucediendo en el termómetro que está marcando las temperaturas. >> con 83 grados. >> en san francisco y también viendo los descensos de 48 grados y las condiciones. >> que están dando términos estas condiciones secas. >> y viendo lo que está pasando con este sistema de alta presión. >> que se mantiene sobre todo en la zona lo largo de la costa. >> por lo que están emitiendo una alerta. >> en santa cruz de las montañas de sonoma. >> en el área de santa clara. >> que se mantendrá vigente hasta las 4:00 de la tarde el día de mañana. >> con fuertes vientos también. >> don actualmente estaremos registrando entre 20:30 grados en las próximas horas. >> y también en la noche máximas para el día de mañana. >> viendo el acento nada más con temperaturas de 90 grados. >> también las temperaturas 91 grados en

think about the millions of people who have alzheimer's disease. that's a huge bill. >> yeah.h that's a big number. it also appears that the -- in the trials, when they went back and looked -- kind of looked things over, they had just increased the amount that they had given people and that contributed to the efficacy going up. >> so basically, they said over time when they got more data, it had just been continuing with those trials between when they looked a look at these two slices more patients had been on a higher dose of the drug in the later snap shot of the data and that's how they described why it looked better later than earlier. >> any trial lessons from eli lilly? initially, had promising data but ended up failing in 2016. >> some people are wondering if this is going to potentially resurrect old programs with this same approach targeting amaloid data in the brain. whether the drug actually targeted it in the right way or even got into the brain enough in even older programs, people said those people didn't even have build ups of plaque in the brain. so there is so

should alzheimer's for ten years. fortunately we were able to get the money to take care of her and her needs. also my cousin is in federal prison and i want to thank you for the justice society bill you just represented. my question to you for all of us young millennials author in her 20s and 30s, just starting out from college, what can we 30 do, not just on social media, which we can see a change from that. we look your platform and what you accomplish from that. but what can we do in action outside of social media that can help you. it's a lot of work that you are doing. in all areas of government. t. the things that we brought today in the sample meeting. but what can we do to help you in your platform. to thrive and really helped change this government. >> of course, thank you so much. it's a really great question. what is the things that i think is that it's not just about helping me. because i am just part of a larger movement. i am here because people of critical mass of people, have demanded justice in our c

more than 2,000 show the drug appear to slow declines associated with alzheimer's. that da ta on patients and they had a higher dose in later analysis given how many people have alzheimer's disease, almost 6 million americans, it would be major advance and major boom for business >> is this also big news for the same sort of class of drugs that attack the plaque in the brain which is at the root of alzheimer's? >> yeah. you see failure after failure there. it almost seemed like finally ready to let go of that. so many of those trials have failed and companies have discounted them. it's unclear if they will try to look back and resuscitate them in the same way. it's not the same situation where they will have more data but it does make you wonder about the science here we thought everybody had gotten it long for so long. does this provide that idea. >> thank you >>> that jump in biogen having a basic impact on the stock standings. they are moved into third place depe behind nick. >>> coming up, a new antisocial bill in congress targeting facebook and other huge socia

we have got pressures coming the growth ine alzheimer's. you have to ask yourself, what in the world have we been doing? why has that been our set up priorities? it is staggering -- set of priorities? it is staggering to me. if you are looking at this planet from another planet and saw our record over the last 20-30 years, you would ask, do these people even care about their children? do they even care about their children? on our planet, we care about the next generation. on our planet, we care about what our country's role in the world is going to be. what is wrong with these people? >> other questions? i have two final questions. >> i did not mean to depress everybody. [laughter] don't be depressed, because the answer is, stop doing that and start investing in america again. >> jim flanagan from the college here and then i west my question. >> welcome again. member --ely lost a unfortunately lost a member of my family in iraq. my son is a junior in high school. he is here today actually. if you are elected president, what are you going t

she had alzheimer's for ten years. fortunately we were able to get the money to take care of her and her needs. also my cousin is in federal prison and i want to thank you for the just society bill that you just represented. my question to you for all us young millennials in our 20s and 30s and just starting out from college, what can we do not just on social media, look at your platform and what you have accomplished but what can we do in actions outside of social media that can help you? we know it is a lot of work you are doing and all areas of government and all the things we brought up today in this townhall meeting but what can we do to help you and your platform to thrive and help change this government? >> really great question. one of the things that i think is best to do is it is not just about helping me because i'm part of a larger grassroots movement. i'm here because a critical mass of people have demanded justice in the criminal justice system, environmental justice, education, etc.. one of the best thin

i am an advocate with the alzheimer's association. thank you for signing on to approving the hope for alzheimer's act. what would you do to continue to cure by 2025?nd a if you are elected president,, what would you do to stay on track to find a cure for alzheimer's? >> we have talked about this before so thank you for your advocacy. the cost will eat us alive if we don't find a care. i believe we can find a cure. i would dramatically increase investment in nih, not just for alzheimer's but other basic research as well. we have cut our investments in our country, which includes nih, by 35% since ronald reagan was president. all of our investments in infrastructure, education, national forest, we have slashed it by 35% while we have told ourselves our priorities are borrowing $5 trillion from the chinese for the privilege of giving the wealthiest people in america tax cuts. it has been our priority. it has been trump's priority. we could have invested in giving the teacher arrays or giving every kid in america preschool, making social

. >> biogen will apply early next year for approval for an alzheimer's drug it's really kind of a shocking turnaround adjusting the drug didn't work, they stopped those clinical trials what happened in december, they did an interim look at the study. that was on 1700 patients. in march, they announced they were going to stop the trials. between those two times, they got more data. and as of today, they say they had data on more than 2,000 patients 300 more patients and patients who using higher doses of the drug it met the goals on those high-dose patients it looked like it will work this is such a big deal because so many people have alzheimer's disease. >> a real breakthrough for this, obviously, that would be massive. the wall street reaction, by the way, mixed the news today doesn't agree approval and seeing a lot of these questions remain everyone seems to be saying, look, we don't want to get too far ahead of ourselves. >> that's right, because the stock has been -- we also have another graphic here, the failure in alzheimer's disease 9 99.6%. this has been a tough area the skepticis

alzheimer's was the next future. able to turn this around, who knows what is in the data. they are willing to go back and get this approved. if that is the case, you're talking about a multibillion-dollar stream of revenue for the company and that is why you are seeing shares up this morning. alix: huge down. romaine: and the gap up we are getting today was recouping what we have lost going back to march 21. alix: it is time for bottom line. we'll take a look at companies worth watching. the first is wework. adam neumann will be stepping down from the company's board. joining us is sonali basak. stepping down but getting payouts from softbank? about $1.7 million -- about $1.7 billion. this is basically an unwind of his stake in the company and his connection overall, right? sonali: they are asking him to please leave. it seems to be a nuanced wrap in a bow. they have been running out of cash. it has been reported that a softbank executive would be taking over as chairman of the board that has not been announced yet,

current drugs only help with the symptoms of alzheimers — so if given the go ahead it will be a major the treatment of the disease. the man whose extradition case sparked the past six months of protests in hong kong has agreed to return to taiwan voluntarily, to face prosecution for murder. it's alleged chan tong—kai murdered his pregnant girlfriend during a holiday in taiwan last year. he fled back to hong kong, which has no extradition deal with taiwan, and his case was cited when the government proposed amending the law. the former top us diplomat in ukraine has testified that he was told president trump had made the release of military aid to ukraine contingent on a public declaration from kyiv that it would conduct an investigation into the former democratic vice—president, joe biden. william taylor's evidence to congressional committees leading an impeachment inquiry was met with gasps in the closed—door hearing. donald trump has denied using a threat to withdraw military aid as political leverage. david willis reports. william taylor, career diplomat, man of the establishment.